alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT DECEMBER 31, 1996, AND THE STATEMENTS OF OPERATIONS FOR THE TWELVE
MONTHS ENDED DECEMBER 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       1,004,400
<SECURITIES>                                         0
<RECEIVABLES>                                  222,200
<ALLOWANCES>                                    35,100
<INVENTORY>                                     70,600
<CURRENT-ASSETS>                                     0
<PP&E>                                      13,263,100
<DEPRECIATION>                              10,104,300
<TOTAL-ASSETS>                               4,605,200
<CURRENT-LIABILITIES>                        1,842,500
<BONDS>                                      1,042,800
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 4,605,200
<SALES>                                              0
<TOTAL-REVENUES>                             5,243,500
<CGS>                                                0
<TOTAL-COSTS>                                3,745,600
<OTHER-EXPENSES>                              (43,600)
<LOSS-PROVISION>                               126,400
<INTEREST-EXPENSE>                             187,900
<INCOME-PRETAX>                              1,353,600
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,353,600
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,353,600
<EPS-PRIMARY>                                    44.76
<EPS-DILUTED>                                        0
        

</TABLE>
EXHIBIT 32.2

          CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
           PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Yunjie Fang, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  the Annual Report on Form 10-K of HQ Global Education Inc. for the
          year ended August 31, 2010 (the "Report") fully complies with the
          requirements of Section 13(a) or 15(d) of the Securities Exchange Act
          of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of HQ Global Education Inc.

Dated: November 29, 2010
                                        /s/ Yunjie Fang
                                        ----------------------------------------
                                        Chief Financial Officer
                                        (Principal Financial Officer and
                                        Principal Accounting Officer)

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to HQ Global Education Inc. and will
be retained by HQ Global Education Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.
**EXHIBIT 31.2**

**CHIEF FINANCIAL OFFICER CERTIFICATION**

**REQUIRED BY RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE**

**ACT OF 1934, AS AMENDED**

I, Peter S. Garcia, certify that: 

1. I have reviewed this annual report on Form 10-K of Marina Biotech, Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on myknowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periodspresented in this report; 

4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and wehave: 

a) designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in whichthis report is being prepared; 

b) designed such internal control over financial reporting, or caused suchinternal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance withgenerally accepted accounting principles; 

c) evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; 

d) disclosed in this report any change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation, to theregistrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function): 

a) all significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and 

b) any fraud, whether or not material, thatinvolves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: March 23, 2011
H. Res. 1525 

In the House of Representatives, U. S., 

October 3, 2008. 

Resolved, That upon adoption of this resolution it shall 

be in order to take from the Speaker’s table the bill (H.R. 

1424) to amend section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health 

Service Act, section 9812 of the Internal Revenue Code of 

1986 to require equity in the provision of mental health and 

substance-related disorder benefits under group health plans, 

to prohibit discrimination on the basis of genetic information 

with respect to health insurance and employment, and for 

other purposes, with the Senate amendments thereto, and to 

consider in the House, without intervention of any point of 

order, a single motion offered by the chairman of the Committee on Financial Services or his designee that the House 

concur in the Senate amendments. The Senate amendments 

and the motion shall be considered as read. The motion shall 

be debatable for 90 minutes, with 60 minutes equally divided 

and controlled by the chairman and ranking minority member 

of the Committee on Financial Services, and 30 minutes 
2 

•HRES 1525 EH 

equally divided and controlled by the chairman and ranking 

minority member of the Committee on Ways and Means. The 

previous question shall be considered as ordered on the motion to final adoption without intervening motion or demand 

for division of the question. 

SEC. 2. During consideration of the motion to concur 

pursuant to the first section of this resolution, notwithstanding the operation of the previous question, the Chair 

may postpone further consideration of such motion to such 

time as may be designated by the Speaker. 

Attest: 

Clerk.
LIST OF ACRONYMS FOR THE DIFFICULT TO TEST SUBSTANCE WORKSHOP

ACI American Cleaning Institute

ACR Acute

- to

- Chronic Ratio

AF Assessment Factors

ASTM American Society for Testing and Materials

BP Boiling Point

CAS Chemical Abstracts Service Registry

CoC Concentration of Concern

CFR Code of Federal Regulations

ChV Chronic Toxicity Value

DMF Dimethylformamide

DMSO Dimethyl sulfoxide

DOC Dissolved Organic Carbons

EC Effective Concentration

EC 50 Median Effective Concentration

ECOSAR Ecological Structure Activity Relationships

E E C Estimated Environmental Concentration

E

- FAST Exposure, Fate Assessment Screening Tool

EPA Environmental Protection Agency

EPI Suite TM Estimation Programs Interface Suite

FR Federal Register

GLP Good L aboratory P ractice

IFRA International Fragrance Association

K OC Sediment Adsorption Coefficient

K OW Octanol/water Partitioning Coefficient

LC 50 Median Lethal Concentration

LOEC Lowest Observable Effect Concentration

LOQ Limit of Qua nti t ation

MATC Maximum Acceptable Toxic Concentration

mg/L Milligrams per Liter

μg/L Mi cro grams per Liter

MP Melting Point

MW Molecular Weight

NOEC No Observable Effect Concentration

OECD Organization for Economic Cooperation and Development

OPP Office of Pesticide Programs

OPPT Office of Pollution Prevention and Toxics

PBT Persistent, Bioaccumulative, and Toxic

PEC Predicted Environmental Concentration

PMN Premanufacture Notice

PNEC Predicted No

- Effect Concentration

ppb Parts Per Billion

ppm Parts Per Million

QSAR Quantitative Structure Activity Relationships

RIFM The R esearch I nstitute for F ragrance M aterialsRFS II Renewable Fuel Standard Program (RFS2)

S Water Solubility

SAR Structure Activity Relationship

SETAC Society of Environmental Toxicology and Chemistry

SIDS Screening Information Data Set

SMILES Simplified Molecular Input Line Entry System

SWC Surface Water Concentration

TEG Triethylene glycol

TOC Total Organic Carbon

TSCA Toxic Substance Contr ol Act

UF Uncertainty Factor

VP Vapor Pressure

WAF Water Accommodated Fraction

WSOL Water Solubility

7Q10 T he lowest stream flow for seven consecutive days that would be expected to

occur once in ten years
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

REGION Ill 

1650 Arch Street 

Philadelphia, Pennsylvania 19103-2029 

Mr. David K. Paylor, Director 

Virginia Department of Environmental Quality 

P.O. Box 1105 

Richmond, Virginia 23218 

Dear Mr. Paylor: 

MAR 1 5 Z014 

On February 18, 2014, the U.S. Environmental Protection Agency (EPA) received a revision to 

the Virginia State Implementation Plan (SIP) from the Virginia Department of Environmental Quality 

pertaining electronic SIP transmittals. EPA has determined that the submittal is administratively and 

technically complete. 

If members of your staff have any questions, they may direct them to Sharon McCauley, Air 

Protection Division, at (215) 814-3376, or at mccauley.sharon@epa.gov. She is the principal contact for 

this rulemaking. 

Sincerely, 

.. [) i(\.l<(:L 0 WI 

Diana Esher, Director 

Air Protection Division 

ft 

~.1 Printed on 100% recycled/recyclable paper with 100% post-consumer fiber and process chlorine free. 

Customer Service Hotline: 1-800-438-2474
From: mpinto@ascensionpress.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:45:31 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Matthew Pinto

West Chester, PA 19382
#### UNITED STATES of America, Plaintiff—Appellee, v. William George YOUNG, Defendant—Appellant.

No. 04-30289.

United States Court of Appeals, Ninth Circuit.

Aug. 15, 2005.

James P. Hagarty, Esq., Office of the U.S. Attorney, Yakima, WA, for PlaintiffAppellee.

Edwin F. Alden, Esq., Kennewick, WA, for Defendant-Appellant.

Eastern District of Washington, Spokane. D.C. No. CR-03-02104-WFN.

Before: THOMPSON, MCKEOWN, and GOULD, Circuit Judges.

ORDER

The Petition for Rehearing is DENIED.

The full court has been advised of the Petition for Rehearing En Banc and no judge of the court has requested a vote on the Petition for Rehearing En Banc. Fed. R.App. P. 35. Appellant’s Petition for Rehearing En Banc is also DENIED.

The federal Plaintiff-Appellee’s Motion to Publish the Court’s memorandum disposition dated July 8, 2005 is GRANTED.

The memorandum disposition issued on July 8, 2005 is WITHDRAWN, and an opinion will be filed in due course. The Appellant shall be permitted a Petition for Rehearing and/or a Petition for Rehearing *652En Banc with regard to the opinion that will subsequently be filed.
Before the First Division,

FEBRUARY 13, 1962

No. 66449.

#### F. W. Myers & Co., Inc., for a/c Ayerst Laboratories, Inc. *v.*United States,

protests 60/16917 and 60/22135 (Ogdensburg).

Opinion by

Wilson, J.

In accordance with stipulation of counsel that the merchandise, invoiced as “Primidone B. P.,” is, in fact, “5-Ethyl-5-phenyl-hexa-hydropyrimidine-4: 6-dione,” the claim of the plaintiff was sustained.
From: Thomas F Swearingen

To: E-OHPSCA2713.EBSA

Subject: women"s health

Date: Saturday, August 13, 2011 10:06:49 AM

Please follow the recommendations of the Institute of Medicine in giving all women access to birth

control through employers. Please do not allow any "religious refusal" exemptions as this allows some

groups to make decisions against every woman's right to contraceptive services.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### International Trade Commission

          - [USITC SE-23-045]

# Agency Holding the Meeting:

 United States International Trade Commission.

# TIME AND DATE: 

September 25, 2023 at 11:00 a.m.

# PLACE: 

Room 101, 500 E Street SW, Washington, DC 20436, Telephone: (202) 205-2000.

# STATUS: 

Open to the public.

# MATTERS TO BE CONSIDERED:

1. Agendas for future meetings: none.

2. Minutes.

3. Ratification List.

4. Commission vote on Inv. Nos. 701-TA-684 and 731-TA-1597-1598 (Final)(Gas Powered Pressure Washers from China and Vietnam). The Commission currently is scheduled to complete and file its determinations and views of the Commission on October 13, 2023.

                        5.                         *Outstanding action jackets:*                         none.                    

# CONTACT PERSON FOR MORE INFORMATION: 

Sharon Bellamy, Supervisory Hearings and Information Officer, 202-205-2000.

The Commission is holding the meeting under the Government in the Sunshine Act, 5 U.S.C. 552(b). In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting.

By order of the Commission.

Issued: September 15, 2023.

Sharon Bellamy,

Supervisory Hearings and Information Officer.

[FR Doc. 2023-20423 Filed 9-18-23; 11:15 am]

BILLING CODE 7020-02-P
Before the First Division,

February 24, 1966

No. 69803.

protests 61/4346, etc. (New York).

#### Remco Industries, Inc. *v.*United States,

Opinion by

Oliver, J.

In accordance with stipulation of counsel that the merchandise consists of electric motors similar in all material respects to those the subj eot of Abstract 66961, the claim of the plaintiff was sustained.
From: bbrandt523@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:00:13 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Bev Brandt

Zion, IL 60099
No. 252, Misc.

#### Jackson *v.*Maroney, Correctional Superintendent, et al.

Petitioner *pro se.*

*John K. Best*for respondents.

Supreme Court of Pennsylvania. Certiorari denied.
<PAGE>

                                                                    Exhibit 11
                                                                    ----------
                    PACIFIC TELESIS GROUP AND SUBSIDIARIES
                       COMPUTATION OF EARNINGS PER SHARE
     (Dollars in millions, except per share amounts; shares in thousands)

                                            For the Year Ended December 31,
                                               1995       1994        1993 
                                           --------------------------------

Net income (loss) ........................ $(2,312)     $1,159     $(1,504)
                                           ========    =======     ========
Weighted average number of common
   shares outstanding .................... 425,996     423,969     414,171 

Common stock equivalent shares
   applicable to stock options ...........     389         818       1,172 
                                           --------    -------     --------

Total number of shares for computing
   primary earnings per share ............ 426,385     424,787     415,343 

Incremental shares for computing fully
   diluted earnings per share ............     323           0         538 
                                           -------     -------     --------
Total number of shares for computing
   fully diluted earnings per share ...... 426,708     424,787     415,881 
                                           =======     =======     ========
Earnings (loss) per common share
   (as reported)..........................  $(5.43)      $2.73      $(3.63)
Primary earnings (loss) per share ........  $(5.42)      $2.73      $(3.62)
Fully diluted earnings (loss) per share ..  $(5.42)      $2.73      $(3.62)

Earnings per share amounts for the three-years ended December 31, 1995, as
reported in the Consolidated Statements of Income, were based on the weighted
average number of common shares outstanding for the respective years. Primary
and fully diluted earnings per share amounts were not shown in the
Consolidated Statements of Income, as they differ from the reported earnings
per share amounts by less than three percent.